All Pharma News
Astellas writes down another piece of its Audentes gene therapy acquisition

Astellas writes down another piece of its Audentes gene therapy acquisition
Amber Tong ENDPTS
16 Apr 2024
Share Share
FDA lifts clinical hold on Astellas Pompe gene therapy

FDA lifts clinical hold on Astellas Pompe gene therapy
Nick Paul Taylor FIERCE BIOTECH
21 Jan 2023
Share Share
Astellas takes $540M impairment charge over Audentes` gene therapy trial hold

Astellas takes $540M impairment charge over Audentes` gene therapy trial hold
Ben Adams FIERCE BIOTECH
28 Apr 2021
Share Share
Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments

Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments
Marta Figueiredo PhD MUSCULARDYSTROPHYNEWS
02 Apr 2021
Share Share
Audentes CEO exits as Astellas rebrands a gene therapy buyout

Audentes CEO exits as Astellas rebrands a gene therapy buyout
Ned Pagliarulo BIOPHARMADIVE
01 Jan 2021
Share Share
Audentes sees FDA hold lifted after 3 trial deaths

Audentes sees FDA hold lifted after 3 trial deaths
Ben Adams FIERCE BIOTECH
31 Dec 2020
Share Share
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program

Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Ben Adams FIERCE BIOTECH
29 Dec 2020
Share Share
Taysha Gene Therapies Builds Experienced Executive Leadership Team

Taysha Gene Therapies Builds Experienced Executive Leadership Team
BUSINESSWIRE
31 Aug 2020
Share Share
Astellas` Audentes reports 3rd death in gene therapy trial

Astellas` Audentes reports 3rd death in gene therapy trial
Nick P. Taylor FIERCE BIOTECH
22 Aug 2020
Share Share
Audentes says third study patient passed away in ASPIRO trial evaluating AT132

Audentes says third study patient passed away in ASPIRO trial evaluating AT132
PHARMABIZZ
21 Aug 2020
Share Share